Current Oncology Reports

Current Oncology Reports

CURR ONCOL REP
影响因子:5
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Springer US
发刊时间:1999
发刊频率:12 issues per year
收录数据库:SCIE/Scopus收录
ISSN:1523-3790

期刊介绍

This journal aims to review the most important, recently published clinical findings in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those affected by cancer.We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as cancer prevention, leukemia, melanoma, neuro-oncology, and palliative medicine. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.
本杂志旨在回顾肿瘤学领域最重要的、最近发表的临床发现。通过提供国际专家清晰、有见地、平衡的贡献,该杂志旨在为所有参与癌症患者护理的人服务。我们通过任命国际权威人士担任关键主题领域的部分编辑来实现这一目标,如癌症预防、白血病、黑色素瘤、神经肿瘤学和姑息医学。而版块编辑则会选择一些主题,让顶尖专家为这些主题撰写全面的评论文章,这些文章强调新的发展和最近发表的重要论文,并通过注释参考文献列表突出显示。一个国际编辑委员会审查年度目录,建议他们国家/地区特别感兴趣的文章,并确保主题是最新的,包括新兴的研究。还提供了该领域知名人士的评论。
年发文量 137
国人发稿量 0
国人发文占比 0%
自引率 -
平均录取率-
平均审稿周期 较慢,6-12周
版面费 US$4190
偏重研究方向 ONCOLOGY-
期刊官网 https://www.springer.com/11912
投稿链接 https://www.editorialmanager.com/conp

期刊高被引文献

HIF Inhibitors: Status of Current Clinical Development
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0752-z
CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0769-3
Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0770-x
Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0763-9
Updates on Management of Gastric Cancer
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0820-4
PI3K Inhibitors in Breast Cancer Therapy
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0846-7
Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0852-9
Plasma Cell Leukemia: Definition, Presentation, and Treatment
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0754-x
A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0757-7
How Each Component of Betel Quid Is Involved in Oral Carcinogenesis: Mutual Interactions and Synergistic Effects with Other Carcinogens—a Review Article
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0800-8
Malnutrition in Older Adults with Cancer
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0829-8
Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0799-x
Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0825-z
How We Treat Recurrent Glioblastoma Today and Current Evidence
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0834-y
Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0779-1
The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0827-x
Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0775-5
Increasing Role of Oncoplastic Surgery for Breast Cancer
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0860-9
Novel Imaging in Detection of Metastatic Prostate Cancer
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0780-8
Clinical and Genomic Considerations for Variant Histology in Bladder Cancer
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0772-8
Management of Residual Mass in Germ Cell Tumors After Chemotherapy
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0758-6
Bispecific Antibodies in Hematologic Malignancies: When, to Whom, and How Should Be Best Used?
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0759-5
Cardiac Complications in the Adult Bone Marrow Transplant Patient
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0774-6
Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0835-x
Novel Targets for the Treatment of Melanoma
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0849-4
Novel Approaches for Treating Pain in Children
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0766-6
Sinonasal Undifferentiated Carcinoma
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0776-4
Neoadjuvant Stereotactic Radiosurgery: a Further Evolution in the Management of Brain Metastases
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0817-z
The Role of Natural Killer Cells as a Platform for Immunotherapy in Pediatric Cancers
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0837-8
Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0861-8
Current and Emerging Methods of Management of Ependymoma
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0826-y
Correction to: Systemic Therapy of Central Nervous System Metastases of Breast Cancer
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0813-3
Communicating with Adolescents and Young Adults about Cancer-Associated Weight Loss
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0765-7
How Recent Advances in Biology of Waldenström’s Macroglobulinemia May Affect Therapy Strategy
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0768-4
Issues with Fertility in Young Women with Breast Cancer
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0812-4
Management of Adrenocortical Carcinoma
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0773-7
Contemporary Management of Parapharyngeal Tumors
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0853-8
Novel Immunotherapy Combinations
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0851-x
When Can We Avoid Postmastectomy Radiation Following Primary Systemic Therapy?
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0850-y
Transfusion as a Palliative Strategy
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0832-0
When to Add Additional Anti-HER2 Therapy to Adjuvant Trastuzumab
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0848-5
The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0792-4
Managing Pain in the Older Cancer Patient
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0854-7
Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0831-1
Predicting Life Expectancy for Older Adults with Cancer in Clinical Practice: Implications for Shared Decision-making
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0821-3
Contemporary Approach to Locally Advanced Oral Cavity Squamous Cell Carcinoma
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0845-8
Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0856-5
Primary Melanoma: from History to Actual Debates
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0843-x
Targeting Barriers of Systems of Care in a Growing Multi-disciplinary Field
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0785-3
On Heartbreak in Oncology
来源期刊:Current Oncology ReportsDOI:10.1007/s11912-019-0755-9

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
0.00%26.23%-2.4%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
ONCOLOGY
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学2区
ONCOLOGY 肿瘤学
2区
2023年12月升级版
医学2区
ONCOLOGY 肿瘤学
3区
2022年12月旧的升级版
医学2区
ONCOLOGY 肿瘤学
3区